New stroke device trial halted early – too soon to tell

NCT ID NCT05107206

Terminated Disease control Sponsor: NeuroVasc Technologies Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new device called Envi™-SR for removing blood clots in people having a severe ischemic stroke. The goal was to see if it works as well as devices already approved by the FDA. However, the trial was stopped early after enrolling only 12 people, so we don't have enough information to know if the new device is safe or effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Envi™-SR Thrombectomy device
What this could lead to: If successful, this device could offer another option for quickly removing blood clots in stroke patients, potentially improving recovery.
What could go wrong: The trial was terminated early with only 12 participants, so we have very little data. It is unclear if the device is safe or effective compared to existing tools.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE

Contacts and locations

Locations

Advocate Aurora Health

Downers Grove, Illinois, 60068, United States
Baptist Health Research Institute

Jacksonville, Florida, 32207, United States
North Shore University Hospital

Manhasset, New York, 11030, United States
Providence Medical Foundation

Irvine, California, 92612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.